Risperdal Marketing Blocks Weren't For Kids, Pa. Jury Told
A Philadelphia trial over a Johnson & Johnson unit's allegedly reckless conduct in pushing the antipsychotic medication Risperdal for use in adolescents devolved into playtime on Thursday as a company witness...To view the full article, register now.
Already a subscriber? Click here to view full article